We formed Edgewood Oncology because of the synergistic mechanism of action and promising safety and anti-tumor data that was observed with BTX-A51 in Phase 1 in AML and solid tumor patients. We look forward to further developing this compound using a precision medicine approach in patient population
Total raised: $20M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.03.2024 | Series A | $20M | - |
Mentions in press and media 5
| Date | Title | Description |
| 26.03.2024 | Edgewood Oncology: A Rising Star in Biotechnology | Edgewood Oncology, a clinical-stage biotechnology company based in Brookline, MA, has made waves in the industry by securing a whopping $20 million in Series A financing. This funding, led by Alta Partners, will propel the company's innovat... |
| 26.03.2024 | Edgewood Oncology Closes $20 Million To Help Patients With Hematologic Malignancies And Genetically-Defined Solid Tumors | Edgewood Oncology (a clinical-stage biotechnology company focused on delivering BTX-A51 to patients with hematologic malignancies and genetically defined solid tumors) has emerged from stealth mode with $20 million in Series A funding backe... |
| 25.03.2024 | Edgewood Oncology Secures $20 Million in Series A | BROOKLINE, MA, Edgewood Oncology, a clinical-stage biotechnology company emerged from stealth with $20 million in Series A financing. >> Click here for more funding data on Edgewood Oncology >> To export Edgewood Oncology fu... |
| 25.03.2024 | Edgewood Oncology Raises $20M in Series A Funding | Edgewood Oncology, a Brookline, MA-based clinical-stage biotechnology company focused on delivering BTX-A51 to patients with hematologic malignancies and genetically-defined solid tumors, raised $20M in Series A funding. The round was led b... |
| - | Edgewood Oncology | “We formed Edgewood Oncology because of the synergistic mechanism of action and promising safety and anti-tumor data that was observed with BTX-A51 in Phase 1 in AML and solid tumor patients. We look forward to further developing this compo... |